Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling
- PMID: 17992260
- PMCID: PMC2066194
- DOI: 10.1172/JCI28115
Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling
Abstract
Mammalian TLRs are central mediators of the innate immune system that instruct cells of the innate and adaptive response to clear microbial infections. Here, we demonstrate that human epithelial TLR4 directly protected the oral mucosa from fungal infection via a process mediated by polymorphonuclear leukocytes (PMNs). In an in vitro epithelial model of oral candidiasis, the fungal pathogen Candida albicans induced a chemoattractive and proinflammatory cytokine response but failed to directly modulate the expression of genes encoding TLRs. However, the addition of PMNs to the C. albicans-infected model strongly upregulated cytoplasmic and cell-surface epithelial TLR4 expression, which correlated directly with protection against fungal invasion and cell injury. C. albicans invasion and cell injury was restored by the addition of TLR4-specific neutralizing antibodies and knockdown of TLR4 using RNA interference, even in the presence of PMNs, demonstrating the direct role of epithelial TLR4 in the protective process. Furthermore, treatment with neutralizing antibodies specific for TNF-alpha resulted in strongly reduced TLR4 expression accompanied by augmented epithelial cell damage and fungal invasion. To our knowledge, this is the first description of such a PMN-dependent, TLR4-mediated protective mechanism at epithelial surfaces, which may provide significant insights into how microbial infections are managed and controlled in the oral mucosa.
Figures







Similar articles
-
Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis.Microbiology (Reading). 2004 Sep;150(Pt 9):2807-2813. doi: 10.1099/mic.0.27169-0. Microbiology (Reading). 2004. PMID: 15347740
-
Epithelial cells and innate antifungal defense.J Dent Res. 2010 Jul;89(7):666-75. doi: 10.1177/0022034510368784. Epub 2010 Apr 15. J Dent Res. 2010. PMID: 20395411 Free PMC article. Review.
-
Melanocytes and melanin represent a first line of innate immunity against Candida albicans.Med Mycol. 2014 Jul;52(5):445-54. doi: 10.1093/mmy/myu026. Epub 2014 Jun 15. Med Mycol. 2014. PMID: 24934806
-
Toll-like receptor 4 (TLR4) is the major pattern recognition receptor triggering the protective effect of a Candida albicans extracellular vesicle-based vaccine prototype in murine systemic candidiasis.mSphere. 2024 Aug 28;9(8):e0046724. doi: 10.1128/msphere.00467-24. Epub 2024 Jul 22. mSphere. 2024. PMID: 39037263 Free PMC article.
-
Immunity to Candida.Oral Dis. 2002;8 Suppl 2:69-75. doi: 10.1034/j.1601-0825.2002.00015.x. Oral Dis. 2002. PMID: 12164664 Review.
Cited by
-
Mucosal candidiasis elicits NF-κB activation, proinflammatory gene expression and localized neutrophilia in zebrafish.Dis Model Mech. 2013 Sep;6(5):1260-70. doi: 10.1242/dmm.012039. Epub 2013 May 29. Dis Model Mech. 2013. PMID: 23720235 Free PMC article.
-
Different Host Immunological Response to C. albicans by Human Oral and Vaginal Epithelial Cells.Mycopathologia. 2019 Feb;184(1):1-12. doi: 10.1007/s11046-018-0301-6. Epub 2019 Jan 1. Mycopathologia. 2019. PMID: 30600418
-
Blood platelets in the progression of Alzheimer's disease.PLoS One. 2014 Feb 28;9(2):e90523. doi: 10.1371/journal.pone.0090523. eCollection 2014. PLoS One. 2014. PMID: 24587388 Free PMC article.
-
Patient Susceptibility to Candidiasis-A Potential for Adjunctive Immunotherapy.J Fungi (Basel). 2018 Jan 9;4(1):9. doi: 10.3390/jof4010009. J Fungi (Basel). 2018. PMID: 29371502 Free PMC article. Review.
-
CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study.BMC Med Genet. 2010 Jan 20;11:10. doi: 10.1186/1471-2350-11-10. BMC Med Genet. 2010. PMID: 20089160 Free PMC article.
References
-
- Godaly G., et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J. Leukoc. Biol. 2001;69:899–906. - PubMed
-
- Backhed F., Hornef M. Toll-like receptor 4-mediated signaling by epithelial surfaces: necessity or threat? Microbes Infect. 2003;5:951–959. - PubMed
-
- Tjabringa G.S., et al. Host defense effector molecules in mucosal secretions. FEMS. Immunol. Med. Microbiol. 2005;45:151–158. - PubMed
-
- Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003;21:335–376. - PubMed
-
- Roeder A., Kirschning C.J., Rupec R.A., Schaller M., Korting H.C. Toll-like receptors and innate antifungal responses. Trends Microbiol. 2004;12:44–49. - PubMed